EPIC PHARMA LLC FDA Approval ANDA 073262

ANDA 073262

EPIC PHARMA LLC

FDA Drug Application

Application #073262

Application Sponsors

ANDA 073262EPIC PHARMA LLC

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL200MG0SULINDACSULINDAC
002TABLET;ORAL150MG0SULINDACSULINDAC

FDA Submissions

ORIG1AP1991-09-06
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1993-12-17
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-07-05
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1994-07-05
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1995-02-13
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1997-06-23
LABELING; LabelingSUPPL18AP2007-12-20
LABELING; LabelingSUPPL20AP2009-06-24
LABELING; LabelingSUPPL21AP2016-05-09STANDARD
LABELING; LabelingSUPPL22AP2021-05-07STANDARD

Submissions Property Types

SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL21Null15
SUPPL22Null7

CDER Filings

EPIC PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 73262
            [companyName] => EPIC PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SULINDAC","activeIngredients":"SULINDAC","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"SULINDAC","activeIngredients":"SULINDAC","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SULINDAC","submission":"SULINDAC","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"SULINDAC","submission":"SULINDAC","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.